Fig. 3.
![Fig. 3. EFS according to the risk group: low-risk group (no mediastinal or visceral involvement, LDH <800 UI/L [—]) and high-risk group (mediastinal and/or visceral involvement and/or LDH ≥800 UI/L [···]) of the patients enrolled in the HM 89 and HM 91 studies.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/92/10/10.1182_blood.v92.10.3591/4/blod42230003x.jpeg?Expires=1722715955&Signature=xTP1IYCv2WIs5wrgsY3~RhZ50mRaEPG19DBNdgFYdAKoeqT6gSEdrmPJtm0DSXMlfpIem07YiGZO8cipbIMbHsleuJPVh4uIXbDKa7~L5I9rsMjCRnLsg9zgCIuLNRGt1PQoaz26CyMwluMJfXo2MD24jq9jvbm8kzYXwgylEogSzq1CRDddM0fdKT4OiibBnOo3absDvrWyxyAHDlTHUH0dQZ31Nhsb3LW88WnF2jqunZ7BtqeGwEZsr3VAyJN1PMdBQqGJnAIxdgPTWFcgTpInCbPZJHCgOfQgB5Asdb2wpcLz0j4sZUPsfcv2C4NFU7~aXwBYhPcDLMi0iSAu0g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
EFS according to the risk group: low-risk group (no mediastinal or visceral involvement, LDH <800 UI/L [—]) and high-risk group (mediastinal and/or visceral involvement and/or LDH ≥800 UI/L [···]) of the patients enrolled in the HM 89 and HM 91 studies.
